Our Opinion

Innocoll Holdings is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“In our pre-clinical animal trial with CollaGUARD, we have studied the performance, primary and secondary endpoints and safety of CollaGUARD in rats.” (Page 101) Read the following document

Company Description

Innocoll Holdings Plc engages in the pharmaceutical business. It involves in the development and manufacturing of pharmaceutical products and medical devices. The company was utilizes proprietary collagen-based technology platform to develop biodegradable and bioresorbable products, and product candidates which can be broken down by the body without the need for surgical removal or applied topically. It distributes the following products: CollatampG globally outside of the United States, Septocoll within Europe and the Middle East, CollaGUARD within Europe, the Middle East and Asia and RegenePro in the United States. The company was founded in December 1997 and is headquartered in Athlone, RN. [Source: MarketWatch]

Company Website: https://www.innocoll.com